Figure 3.
Changes in biomarkers from baseline to 12 months as a continuous variable and subsequent risks of clinical events. Example patients in panel A indicate specific changes in high-sensitivity troponin T; #1 with 8 ng/L at baseline and 16 ng/L at 12 months, #2 with 31 ng/L at baseline and 45 ng/L at 12 months, #3 with 33 ng/L at baseline and 23 ng/L at 12 months, and #4 with 17 ng/L at baseline and 8 ng/L at 12 months. ; GDF-15, growth differentiation factor-15; hsTnT, high-sensitivity troponin T; NT-proBNP, N-terminal pro-B-type natriuretic peptide.
